Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system.

Sethi N, Sondey M, Bai Y, Kim KS, Cadavid D.

Infect Immun. 2006 Nov;74(11):6408-18. Epub 2006 Aug 28.

2.

Coinfection with Borrelia turicatae serotype 2 prevents the severe vestibular dysfunction and earlier mortality caused by serotype 1.

Cadavid D, Garcia E, Gelderblom H.

J Infect Dis. 2007 Jun 1;195(11):1686-93. Epub 2007 Apr 17.

3.

Residual brain infection in relapsing-fever borreliosis.

Cadavid D, Sondey M, Garcia E, Lawson CL.

J Infect Dis. 2006 May 15;193(10):1451-8. Epub 2006 Apr 4.

4.

Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice.

Cadavid D, Pachner AR, Estanislao L, Patalapati R, Barbour AG.

Infect Immun. 2001 May;69(5):3389-97.

5.

The mammalian host response to borrelia infection.

Cadavid D.

Wien Klin Wochenschr. 2006 Nov;118(21-22):653-8. Review.

PMID:
17160603
6.
7.

High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae.

Gelderblom H, Londoño D, Bai Y, Cabral ES, Quandt J, Hornung R, Martin R, Marques A, Cadavid D.

J Neuropathol Exp Neurol. 2007 Mar;66(3):208-17.

8.

Variable small protein (Vsp)-dependent and Vsp-independent pathways for glycosaminoglycan recognition by relapsing fever spirochaetes.

Magoun L, Zückert WR, Robbins D, Parveen N, Alugupalli KR, Schwan TG, Barbour AG, Leong JM.

Mol Microbiol. 2000 May;36(4):886-97.

9.

Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae.

Gelderblom H, Schmidt J, Londoño D, Bai Y, Quandt J, Hornung R, Marques A, Martin R, Cadavid D.

Am J Pathol. 2007 Jan;170(1):251-62.

10.

Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease.

Pennington PM, Allred CD, West CS, Alvarez R, Barbour AG.

Infect Immun. 1997 Jan;65(1):285-92.

11.

In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.

Kazragis RJ, Dever LL, Jorgensen JH, Barbour AG.

Antimicrob Agents Chemother. 1996 Nov;40(11):2632-6.

12.

Extensive interplasmidic duplications change the virulence phenotype of the relapsing fever agent Borrelia turicatae.

Penningon PM, Cadavid D, Bunikis J, Norris SJ, Barbour AG.

Mol Microbiol. 1999 Dec;34(5):1120-32.

13.

Cardiac apoptosis in severe relapsing fever borreliosis.

Londoño D, Bai Y, Zückert WR, Gelderblom H, Cadavid D.

Infect Immun. 2005 Nov;73(11):7669-76.

14.

Structure-function investigation of vsp serotypes of the spirochete Borrelia hermsii.

Mehra R, Londoño D, Sondey M, Lawson C, Cadavid D.

PLoS One. 2009 Oct 30;4(10):e7597. doi: 10.1371/journal.pone.0007597.

15.
16.

Persistent brain infection and disease reactivation in relapsing fever borreliosis.

Larsson C, Andersson M, Pelkonen J, Guo BP, Nordstrand A, Bergström S.

Microbes Infect. 2006 Jul;8(8):2213-9. Epub 2006 May 30.

PMID:
16782384
17.

Interleukin 10 protects the brain microcirculation from spirochetal injury.

Londoño D, Carvajal J, Arguelles-Grande C, Marques A, Cadavid D.

J Neuropathol Exp Neurol. 2008 Oct;67(10):976-83. doi: 10.1097/NEN.0b013e318187a279.

18.

Differential association of Borrelia species with cultured neural cells.

Thomas DD, Cadavid D, Barbour AG.

J Infect Dis. 1994 Feb;169(2):445-8.

PMID:
8106781
19.

Invasion of brain microvascular endothelial cells by group B streptococci.

Nizet V, Kim KS, Stins M, Jonas M, Chi EY, Nguyen D, Rubens CE.

Infect Immun. 1997 Dec;65(12):5074-81.

Items per page

Supplemental Content

Write to the Help Desk